Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia

The prognostic role of lymphocyte doubling time (LDT) in chronic lymphocytic leukemia (CLL) was recognized more than three decades ago when the neoplastic clone’s biology was almost unknown. LDT was defined as the time needed for the peripheral blood lymphocyte count to double the of the initial obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Morabito, Fortunato, Tripepi, Giovanni, Moia, Riccardo, Recchia, Anna Grazia, Boggione, Paola, Mauro, Francesca Romana, Bossio, Sabrina, D’Arrigo, Graziella, Martino, Enrica Antonia, Vigna, Ernesto, Storino, Francesca, Fronza, Gilberto, Di Raimondo, Francesco, Rossi, Davide, Condoluci, Adalgisa, Colombo, Monica, Fais, Franco, Fabris, Sonia, Foa, Robin, Cutrona, Giovanna, Gentile, Massimo, Montserrat, Emili, Gaidano, Gianluca, Ferrarini, Manlio, Neri, Antonino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366564/
https://www.ncbi.nlm.nih.gov/pubmed/34408978
http://dx.doi.org/10.3389/fonc.2021.684621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366564/
https://www.ncbi.nlm.nih.gov/pubmed/34408978
http://dx.doi.org/10.3389/fonc.2021.684621

Ejemplares similares